Advertisement
Advertisement

HIV Care Today


"HAART Era" Now Longer Than "Pre-HAART Era" -- Can We Officially Retire "HAART"?
By Paul E. Sax, M.D.
July 1, 2012

As I've shared before, I'm no fan of the term "HAART" and do everything I can to stop people from using it.

(I'm a fun guy to have at parties.)

I'm returning to this pet peeve of mine because I realized recently that we've passed a milestone of sorts.

Read more …


HIV Testing Roundup, and a Brief Rant
By Paul E. Sax, M.D.
June 29, 2012

I've written so many times about HIV testing that a complete list of the headlines fills two full web pages.

But since the last entry on the topic was more than a month ago, one might think I've lost interest in the topic.

Never!

Read more …


Questions About HIV Cure, and a Very Funny Quote
By Paul E. Sax, M.D.
June 13, 2012

The single case of HIV cure following allogeneic bone marrow transplant is in the news again, this time because of data just presented at "The International Workshop on HIV and Hepatitis Virus Drug Resistance and Curative Strategies" (formerly known as the "HIV Resistance Workshop" -- how's that for rebranding?).

Read more …


NASW's "HIV/AIDS Spectrum Project" Supports the National HIV/AIDS Strategy
By David Fawcett, Ph.D., L.C.S.W.
June 11, 2012

The sun was gleaming on Miami's Biscayne Bay. Palm trees swayed in the gentle breeze and, in the distance, cruise ships were about to set sail for exotic ports. English, Spanish and a dozen other languages drifted through the air as happy people enjoyed the beautiful day. As perfect as it was, the idyllic scene was not all it seemed.

Read more …


SPARTAN: Two-Drug, NRTI-Sparing Strategies Continue to Disappoint
By Paul E. Sax, M.D.
June 8, 2012

Just published is the cleverly named "SPARTAN" study -- spartan because it leaves out both NRTIs and ritonavir -- and the results are very interesting.

Read more …


Cryptococcal Meningitis Study Stopped -- Early HIV Therapy Clearly Harmful
By Paul E. Sax, M.D.
June 2, 2012

From NIAID, an important clinical trial has been stopped early.

Read more …


Generic Nevirapine Now Available -- But the Big One Is Next Year
By Paul E. Sax, M.D.
May 25, 2012

As I'm sure you've heard from your patients -- as I did -- lamivudine (3TC) is now available generically.

Now comes news of the release of several generic formulations of nevirapine (NVP), an effective but always somewhat overshadowed medication. Since its approval way back when in 1996, there has always been a solid reason to pick something else.

Read more …


Advisory Meeting May 10 on Tenofovir/FTC for PrEP, and a Proposed "Niche" for its Use
By Paul E. Sax, M.D.
May 10, 2012

As I've mentioned before, I have no doubt whatsoever that TDF/FTC works for PrEP, provided the person actually takes the med. And while it's not yet approved for this indication, nothing has stopped clinicians from prescribing it already. There's even a CDC "Guidance" on the practice that's now over a year old. Remember, we give TDF/FTC all the time for post-exposure prophylaxis.

Read more …


Do We Really Need Primary Prophylaxis for OIs Anymore?
By Paul E. Sax, M.D.
April 30, 2012

I'm currently on the inpatient consult service and just saw a guy who fits the typical profile of many hospitalized HIV patients in 2012:

Read more …


An Answer to a Commonly Asked Question: Is Treatment 100% Effective in Preventing HIV Transmission?
By Paul E. Sax, M.D.
April 23, 2012

The excitement about "treatment as prevention," and the results of Study 052, have led to many patients asking the question (if not in these words, than using others with a less medical slant), "So if I'm on treatment and doing well, just what is the risk of my transmitting HIV to others?"

Read more …

 < Prev  |  1  |  …  |  5  |  6  |  7  |  8  |  9  |  …  |  14  |  Next > 

Get email notifications every time HIV Care Today is updated.



This article was provided by TheBodyPRO.com.
 

Advertisement